Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 53.17B | 48.30B | 44.50B | 45.58B | 43.77B |
Gross Profit | 7.65B | 4.64B | 4.57B | 5.63B | 4.96B |
EBITDA | 6.57B | 3.31B | 3.77B | 4.45B | 3.86B |
Net Income | 3.93B | 1.48B | 1.87B | 2.76B | 2.29B |
Balance Sheet | |||||
Total Assets | 58.85B | 52.89B | 47.70B | 45.79B | 44.41B |
Cash, Cash Equivalents and Short-Term Investments | 12.32B | 8.97B | 6.77B | 9.36B | 7.89B |
Total Debt | 1.22B | 1.18B | 1.52B | 1.02B | 344.57M |
Total Liabilities | 17.61B | 15.55B | 13.34B | 12.42B | 12.78B |
Stockholders Equity | 41.15B | 37.28B | 34.34B | 33.34B | 31.59B |
Cash Flow | |||||
Free Cash Flow | 3.91B | 2.38B | -2.65B | 1.94B | 4.38B |
Operating Cash Flow | 4.53B | 3.92B | -1.58B | 2.90B | 5.43B |
Investing Cash Flow | -636.98M | -596.42M | -453.43M | -679.83M | -1.60B |
Financing Cash Flow | -1.17B | -1.09B | -377.88M | -401.42M | -505.01M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥44.92B | 11.06 | 0.28% | 10.09% | 170.06% | ||
58 Neutral | HK$14.94B | 4.73 | -2.78% | 5.01% | 3.80% | -54.55% | |
― | €210.08M | 25.52 | 1.94% | 4.48% | ― | ― | |
74 Outperform | ¥45.25B | 12.50 | 3.96% | 0.83% | -14.46% | ||
73 Outperform | ¥49.65B | 17.94 | 3.21% | -23.45% | <0.01% | ||
71 Outperform | ¥43.97B | 8.61 | 3.85% | -1.39% | 16.32% | ||
68 Neutral | ¥47.83B | 19.85 | 4.16% | -9.64% | -31.42% |